Amgen Bone Health Drugs

Listing Websites about Amgen Bone Health Drugs

Filter Type:

FDA Approves Sandoz Biosimilars for Two Blockbuster Amgen …

(1 days ago) WEBBy Frank Vinluan on March 05, 2024. A blockbuster Amgen antibody that treats bone conditions is set to face its first biosimilar competition. The FDA on Tuesday approved …

https://medcitynews.com/2024/03/fda-approves-sandoz-biosimilars-for-two-blockbuster-amgen-bone-drugs/

Category:  Health Show Health

FDA Approves EVENITY™ (romosozumab-aqqg) For The …

(4 days ago) WEBTHOUSAND OAKS, Calif. and BRUSSELS, April 9, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today announced that the U.S. …

https://www.amgen.com/newsroom/press-releases/2019/04/fda-approves-evenity-romosozumabaqqg-for-the-treatment-of-osteoporosis-in-postmenopausal-women-at-high-risk-for-fracture

Category:  Health Show Health

Postmenopausal Osteoporosis Treatment EVENITY® …

(4 days ago) WEBThis study followed 7,180 women with postmenopausal osteoporosis receiving EVENITY ® or placebo (a treatment without medicine) for 12 months. Women receiving EVENITY ® …

https://www.evenity.com/

Category:  Medicine Show Health

4 Ways Amgen Is Working With Organizations to Improve …

(5 days ago) WEB4 Ways Amgen Is Working With Organizations to Improve Osteoporosis Care and Bone Health. Osteoporosis is a bone disease that occurs when the body loses too much bone, makes too little bone, or …

https://www.amgen.com/stories/2021/05/4-ways-amgen-is-working-with-organizations-to-improve-osteoporosis-care-and-bone-health

Category:  Health Show Health

US FDA adds 'boxed warning' for Amgen's bone loss drug Prolia

(3 days ago) WEBJan 19 (Reuters) - The U.S. Food and Drug Administration added a serious warning on the prescribing information for Amgen's (AMGN.O) drug Prolia to treat bone loss as it …

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-revises-labeling-amgens-drug-treat-bone-loss-2024-01-19/

Category:  Food Show Health

Amid patent fight, Sandoz biosimilars to Amgen bone …

(8 days ago) WEBProlia bears the distinction of being the first biologic approved to treat osteoporosis, while Xgeva targets bone cancer. Both drugs won their initial approvals in …

https://www.fiercepharma.com/pharma/sandoz-puts-heat-amgen-fda-approval-first-biosimilars-its-bone-blockbusters-prolia-and-xgeva

Category:  Cancer Show Health

Amgen wins FDA approval for osteoporosis drug Evenity

(7 days ago) WEBAmgen on Tuesday won Food and Drug Administration approval for its osteoporosis treatment Evenity in postmenopausal women at high risk for fracture, two …

https://www.biopharmadive.com/news/amgen-fda-approval-osteoporosis-drug-evenity/552437/

Category:  Food Show Health

UPDATED: Amgen's osteoporosis drug 'romo' comes through with …

(2 days ago) WEBAmgen scored promising Phase III data for its osteoporosis drug romosozumab, providing a pivotal win for the Big Biotech's late-stage pipeline and …

https://www.fiercebiotech.com/r-d/updated-amgen-s-osteoporosis-drug-romo-comes-through-promising-phiii

Category:  Health Show Health

US regulator approves new use for Amgen bone drug

(5 days ago) WEBThe US regulator has approved a new use for Amgen’s blockbuster bone drug Xgeva, to prevent fractures in patients with newly-diagnosed multiple myeloma …

https://pharmaphorum.com/news/us-regulator-approves-new-use-amgen-bone-drug

Category:  Health Show Health

Sandoz wins FDA approval for first two biosimilars for Amgen’s

(3 days ago) WEBSandoz said Tuesday that the FDA signed off on two of its biosimilars to Amgen's bone drug denosumab. But as with other high-profile biosimilar approvals, it's …

https://endpts.com/sandoz-wins-fda-approval-for-first-two-biosimilars-for-amgens-blockbuster-bone-drug/

Category:  Health Show Health

Amgen's New Osteoporosis Drug: It May Not Fly Under Healthcare …

(7 days ago) WEBAmgen's new drug, Prolia, was approved by the FDA to treat post-menopausal osteoporosis (PMO). It will cost about 30% more than rival bone-loss …

https://www.cbsnews.com/news/amgens-new-osteoporosis-drug-it-may-not-fly-under-healthcare-reform/

Category:  Health Show Health

Medical Benefit for EVENITY® (romosozumab-aqqg) EVENITY®

(9 days ago) WEB*All Medical Lives associated with Coverage Restriction for EVENITY ® in DRG Coverage data snapshot as of June 2022 are included in this analysis. † Amgen Assist ® …

https://www.evenityproliahcp.com/access-and-support/medical-benefit-for-evenity

Category:  Medical Show Health

Amgen Sues Novartis to Block Generic Osteoporosis, Bone Cancer …

(4 days ago) WEBThe U.S. Food and Drug Administration approved both drugs in 2010. Thousand Oaks, California-based Amgen sold $3.6 billion worth of Prolia and $2 billion …

https://www.usnews.com/news/top-news/articles/2023-05-02/amgen-sues-novartis-to-block-generic-osteoporosis-bone-cancer-drugs

Category:  Food Show Health

Amgen Important Drug Warning: Prolia® (denosumab) - Bone …

(3 days ago) WEBHealth care providers and patients are encouraged to report adverse events in patients taking Prolia to Amgen at 1-800-77-AMGEN (1-800-772-6436). You are encouraged to …

https://www.bonehealthandosteoporosis.org/news/amgen-important-drug-warning-prolia-denosumab/

Category:  Health Show Health

Heart Safety Clouds Hopes for Amgen, UCB Bone Drug Approval

(8 days ago) WEBThe uncertainty over romosozumab sent shares of Radius Health Inc. up nearly 8%, as its rival drug that won U.S. approval in April will not face competition from …

https://www.the-rheumatologist.org/article/heart-safety-clouds-hopes-amgen-ucb-bone-drug-approval/

Category:  Health Show Health

NEW DATA FROM AMGEN'S PROLIA® (DENOSUMAB) …

(Just Now) WEB" Amgen has long been committed to reducing the impact of osteoporosis, an underdiagnosed and undertreated disease that increases the risk for bone loss and …

https://www.amgen.com/newsroom/press-releases/2023/05/new-data-from-amgens-prolia-denosumab-demonstrates-significant-reduction-in-osteoporotic-fracture-risk-compared-to-alendronate

Category:  Health Show Health

Amgen, Sandoz Settle Clash Over Biosimilars of Blockbuster Drugs

(Just Now) WEBAmgen Inc. and Sandoz Group AG settled a patent-infringement lawsuit over biosimilar versions of Amgen’s Prolia and Xgeva bone-strengthening treatments, …

https://news.bloomberglaw.com/ip-law/amgen-sandoz-settle-clash-over-biosimilars-of-blockbuster-drugs

Category:  Health Show Health

Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug …

(8 days ago) WEBAmgen Inc (NASDAQ:AMGN) reported first-quarter (Q1) earnings Thursday, touting adjusted EPS of $3.96, which beat the analyst consensus estimate of $3.87.. …

https://markets.businessinsider.com/news/stocks/amgen-outlook-is-bright-analyst-predict-obesity-focused-drug-potential-will-drive-shareholder-value-1033327558

Category:  Health Show Health

Is Amgen Stock a Buy for Its 3% Yield? - MSN

(8 days ago) WEBValued at $144.8 billion, Amgen is a large biopharmaceutical company that has a diversified drug portfolio spanning blood disorders, immunology, bone health, …

https://www.msn.com/en-us/money/markets/is-amgen-stock-a-buy-for-its-3-yield/ar-AA1nRAI8

Category:  Health Show Health

Amgen 'Encouraged' by Weight-Loss Drug Interim Data, Shares …

(Just Now) WEBSales of eye drug Tepezza, which Amgen acquired through its Horizon purchase, rose about 5% to $424 million. Excluding Horizon's medications, Amgen said …

https://money.usnews.com/investing/news/articles/2024-05-02/amgen-first-quarter-profit-dips-1-revenue-rises-22

Category:  Health Show Health

Amgen encouraged by preliminary data from weight-loss-drug …

(5 days ago) WEBAmgen scrapped plans to further develop its oral weight-loss drug to focus on MariTide. Amgen AMGN, +0.37% lost $113 million, or 21 cents a share, in the quarter, …

https://www.marketwatch.com/story/amgen-expects-data-from-weight-loss-drug-trial-later-this-year-97de1c09

Category:  Health Show Health

Amgen jumps after teasing weight-loss drug data, rival stocks fall

(2 days ago) WEBAmgen shares headed for their best session since 2009 on Friday after the U.S. drugmaker hinted at encouraging interim trial data on its experimental obesity drug, …

https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-shares-jump-after-teasing-encouraging-weight-loss-data-2024-05-03/

Category:  Health Show Health

bergen-county-drug-case-dismissal-urged-first-such-request …

(2 days ago) WEBThe sample drugs that were seized by police in that case were tested by Shah in October and November 2014, Carbonetti said. Keith Travers, a Bergen County …

https://www.northjersey.com/story/news/2016/03/14/bergen-county-drug-case-dismissal-urged-first-such-request-following-crime-lab-techs-removal/94550512/

Category:  Health Show Health

Amgen Jobs, Employment in Kenilworth, NJ Indeed.com

(7 days ago) WEB14 Amgen jobs available in Kenilworth, NJ on Indeed.com. Apply to Primary Care Physician, Senior Representative, Specialty Representative - Bone Health - Jamaica, …

https://www.indeed.com/q-Amgen-l-Kenilworth,-NJ-jobs.html

Category:  Health Show Health

Best Orthopedic Surgeons in North Bergen, NJ - Bone Surgeons

(4 days ago) WEBDr. Russel Huang, MD. 4.4 (55 ratings) 535 E 70th St New York, NY 10021. See all Orthopedic Surgeons in North Bergen. Leave Feedback.

https://www.healthgrades.com/find-a-doctor/new-jersey/best-orthopedic-surgeons-in-north-bergen

Category:  Health Show Health

Amgen obesity drug MariTide: four key questions going forward

(5 days ago) WEBAmgen said it’s “very encouraged” by interim Phase 2 data for its obesity drug, quickly sparking investor interest. Here are the burning questions surrounding Amgen’s …

https://www.statnews.com/2024/05/03/amgen-new-weight-loss-drug-maritide-what-to-know/

Category:  Health Show Health

Amgen Update on Patent Litigation Related to Sandoz …

(1 days ago) WEBAmgen remains confident in the proven benefits of Prolia ® (denosumab) for millions of patients worldwide with osteoporosis and other bone loss conditions and XGEVA ® …

https://www.amgen.com/newsroom/company-statements/amgen-update-on-patent-litigation-related-to-sandoz-denosumab-biosimilar-products

Category:  Health Show Health

Filter Type: